SCHEMBL29945868

SCHEMBL29945868

CC(C)(C)OC(=O)N1CCC(n2ccc(O)n2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 9/20 0.48
PTPN2 P17706 1/20 0.47
PTPN1 P18031 1/20 0.47
PTPN6 P29350 1/20 0.47
ALDH1A1 P00352 2/20 0.45
CTSD P07339 1/20 0.45
CTSE P14091 1/20 0.45
BACE1 P56817 1/20 0.45
MAPT P10636 2/20 0.44
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
NPC1 O15118 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HCAR1 Q9BXC0 1/20 0.44
KDM4E B2RXH2 1/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15950964 0.87 GPR119 (0.50) GPR119PTPN2PTPN1PTPN6ALDH1A1
SCHEMBL25432161 0.86 NR1H2 (0.40) GPR119PTPN2PTPN1PTPN6KDM4E
SCHEMBL27459322 0.86 GPR119 (0.47) GPR119PTPN2PTPN1PTPN6ALDH1A1
SCHEMBL1582522 0.86 GPR119 (0.47) GPR119PTPN2PTPN1PTPN6ALDH1A1
SCHEMBL1557907 0.86 CTSD (0.49) GPR119PTPN2PTPN1PTPN6ALDH1A1
SCHEMBL3131511 0.86 GPR119 (0.47) GPR119PTPN2PTPN1PTPN6ALDH1A1
SCHEMBL31273679 0.85 GPR119 (0.46) GPR119PTPN2PTPN1PTPN6ALDH1A1
SCHEMBL29098488 0.85 GPR119 (0.46) GPR119PTPN2PTPN1PTPN6ALDH1A1
SCHEMBL20046185 0.85 GPR119 (0.49) GPR119PTPN2PTPN1PTPN6ALDH1A1
SCHEMBL14637172 0.84 STS (0.46) GPR119PTPN2PTPN1PTPN6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049419-A1 PYRAZOLYL COMPOUNDS AS EMOPAMIL BINDING PROTEIN INHIBITORS GENZYME CORPORATION (US) 2025-03-06 WO disclosed
WO-2022184849-A1 GLP-1R AGONISTS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF LES LABORATOIRES SERVIER (FR) 2022-09-09 WO disclosed